cholelithiasis, clonidine
Conditions
Interventions
Experimental group: 26 patients undergoing laparoscopic cholecystectomy or jaw fracture treatment under total intravenous anesthesia. Received 3 mcg / kg of clonidine administered in 100 ml of saline,
Drug
Sponsors
Faculdade de Medicina do ABC
Faculdade de Medicina do ABC
Eligibility
Age
15 Years to 65 Years
Inclusion criteria
Inclusion criteria: Patients ASA I or II. Scheduled for laparoscopic cholecystectomy or jaw fracture treatment in Cariri Regional Hospital. Signing the consent form. Age between 15 and 65 years. Sample : 51 patients.
Exclusion criteria
Exclusion criteria: Drug users who can interfere in the outcomes. Drug Addicts. Physical state above two. Refusal to sign the Instrument of Consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| "Expected outcome: reduction in propofol target dose in the group using clonidine.";Evidenced outcome: The outcome was evidenced by the reduction in target dose of propofol in the group receiving clonidine at a p <0.001. The reduction in propofol target dose was approximately 50% clonidine. Expected outcome: reduction in propofol target dose in the group using clonidine. | — |
Secondary
| Measure | Time frame |
|---|---|
| Expected outcome: reduction in propofol target dose.;Evidenced outcome: reduction in propofol target dose by approximately 50% in the group using clonidine premedication. | — |
Countries
Brazil
Contacts
Public Contacthermes;Luiz batista;de Abreu
Hospital Regional do Cariri;Faculdade de Medicina do ABC
Outcome results
None listed